This information was originally presented at the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.

The NCCN 2015 Nursing Program: Advancing Oncology Nursing Live Webinar Series will provide the oncology nurse with comprehensive and clinically relevant information regarding the management of patients with cancer.

The activating BRAF mutation p.V600E has been identified in many cancers, including colon and lung adenocarcinoma, papillary thyroid cancer, malignant melanoma, and hairy cell leukemia (HCL).

High-dose interleukin-2 (IL-2) is an available treatment option for patients with metastatic melanoma or renal cell carcinoma, and is associated with sustained complete and partial responses in a subset of patients.

Join Jason Rockhill, MD and John Thompson, MD as they present their multidisciplinary expertise on a range of cases pertaining to advanced disease melanoma.

This educational webinar series is designed to addresses the health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with melanoma and related skin cancers, management of both early-stage and lat

This educational webinar series is designed to addresses the health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with melanoma and related skin cancers, management of both early-stage and lat

This educational webinar series is designed to addresses the health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with melanoma and related skin cancers, management of both early-stage and lat

Join Jason Rockhill, MD and John Thompson, MD as they present their multidisciplinary expertise on a range of cases pertaining to advanced disease melanoma.

This recorded webinar, with patient-clinician video case studies, will review the basics of immuno-oncology including the role of the immune system, mechanism of action and pathways of immunotherapy, and compare and contrast conventional and immuno-oncologic cancer treatments.  The short patient